• Home
  • Free Medical Videos
  • Online Pharmacy
  • Ophthalmology
  • Gynecology and Obstetrics
Saturday, June 3, 2023
  • Login
Meduweb
  • Home
  • Free Medical Videos
  • Online Pharmacy
  • Ophthalmology
  • Gynecology and Obstetrics
No Result
View All Result
  • Home
  • Free Medical Videos
  • Online Pharmacy
  • Ophthalmology
  • Gynecology and Obstetrics
No Result
View All Result
Meduweb
No Result
View All Result
Home Online Pharmacy

Erythromycin suspension

Drug Index by Drug Index
May 16, 2019
in Online Pharmacy
215 4
0
Erythromycin suspension

Erythromycin suspension

141
SHARES
231
VIEWS
Share on FacebookShare on Twitter
Contents hide
1 Erythromycin suspension COMPOSITION:
2 Erythromycin suspension PROPERTIES :
3 Erythromycin suspension PHARMACOKINETICS :
4 Erythromycin suspension ANTIMICROBIAL SPECTRUM :
5 Erythromycin suspension INDICATIONS :
6 Erythromycin suspension CONTRAINDICATIONS :
7 Erythromycin suspension PRECAUTIONS :
8 Erythromycin suspension PREGNANCY AND LACTATION :
9 Erythromycin suspension ADVERSE EFFECTS :
10 Erythromycin suspension DRUG INTERACTIONS :
11 Erythromycin suspension DOSAGE AND ADMINISTRATION :
12 Erythromycin suspension OVERDOSAGE :
13 Packing:
14 Storage:
15 Produced by :

Erythromycin suspension COMPOSITION:

Each 5 ml (teaspoonful) of reconstituted suspension contains:
Erythromycin ethylsuccinate 235 mg eq. to erythromycin activity 200 mg.

 Erythromycin suspension PROPERTIES :

Erythromycin Pharco (erythromycin ethylsuccinate) is a broad spectrum macrolide antibiotic for oral administration. Erythromycin is one of the safest antibiotics with high activity against a wide range of Gram-positive and Gram-negative bacteria. Erythromycin is also active against Chlamydiae, Rikettsiae, Actinomyces, Spirochaetes and Mycoplasmas which are resistant to any other antibiotics. Clinical experience with Erythromycin Pharco has demonstrated its high therapeutic efficacy in various infections caused by susceptible organisms, including penicillinase-producing bacteria. Erythromycin Pharco oral suspension is a well tolerated form of erythromycin. Erythromycin Pharco is palatable and safe with clinical superiority that is devoid of the widespread bacterial resistance commonly encountered with other antibiotics.

Erythromycin suspension
Erythromycin suspension

 Erythromycin suspension PHARMACOKINETICS :

Erythromycin ethylsuccinate is readily absorbed from the small intestine after oral administration under fasting and nonfasting conditions. Peak plasma concentrations are achieved within 1 – 2 hours and the antibiotic diffuses into most body tissues and fluids. The drug is concentrated in the liver and excreted largely in the active form in the bile. Less than 5% of the administered dose is excreted in the active form in the urine. There is practically no risk of accumulation in the body in renal failure. Erythromycin is largely bound to plasma proteins and its plasma half-life is about 1.6 hours.

 Erythromycin suspension ANTIMICROBIAL SPECTRUM :

Gram-positive bacteria:
Aerobes: Streptococcus pyogenes, S. pneumoniae, S. faecalis, Staphlococcus aureus,  and Listeria monocytogenes:
Anaerobes : Propionibacterium acnes and Clostridium species.
Gram-negative bacteria :
Aerobes: Neisseria gonorrhoeae, N. meningitidis, Moraxella catarrhalis, Campylobacter jejuni, Haemophilus influenzae, Bordetella pertussis and Legionella pneumophila.
Anaerobes: Some Bacteroides and Fusobacterium species.

 Erythromycin suspension Miscellaneous microorganisms :

Rickettsia prowazekii, R. mooseri, R. rickettsii, Coxiella burnetii, Chlamydia trachomatis, C. pneumoniae, C. psittaci, Mycoplasma pneumoniae, Ureaplasma urealyticum, Treponema pallidum, T. pertenue, Actinomyces species and some protozoa (Entamoeba histolytica).

 Erythromycin suspension INDICATIONS :

Erythromycin Pharco Oral Suspension is indicated for treatment of infections caused by susceptible organisms:
– Upper and lower respiratory tract infections: bronchitis with chronic purulent infections, whooping cough, pneumonia, atypical pneumonia, bronchiectasis, lung abscess, cystic fibrosis, acute respiratory infections with chronic lung diseases (e.g. bronchitis with chronic obstructive pulmonary disease such as emphysema ), empyema and mixed respiratory tract infections. Erythromycin Pharco combined with sulfonamides gives almost complete cure in
H. influenzae-induced infections.
– Ear, nose and throat ( E.N.T. ) infections: otitis media, sinusitis and ulcerative pharyngitis.
– Eye infections: trachoma, inclusion conjunctivitis and other ophthalmic infections.
– Venereal diseases: gonorrhea and syphilis.
– Genital infections: cervicitis, epididymo-orchitis, chronic prostatitis, leptospirosis and pelvic inflammatory disease.
– Gastrointestinal tract infections: cholecystitis, cholangitis, enteritis, traveller’s diarrhea and intestinal amoebiasis (as an adjunct therapy).
– Dermatologic (skin and soft tissue) and bone infections: acne, cellulitis, abscesses, frunculosis, pyoderma, yaws, infected traumatic and post-operative wounds.
– Orodental infections: ulcerative gingivitis, periodontal abscess and following dental manipulations.
– As an adjunct to diphtheria antitoxin to prevent development of diphtheria carrier state and eradicate the causative bacteria in carriers.
– Other infections: relapsing fever, typhus, rocky mountain spotted fever, Q fever, psittacosis, anthrax and listeriosis.
– For prophylaxis against bacterial endocarditis following dental or respiratory tract procedures in patients who have congenital heart disease or rheumatic or other acquired valvular heart disease and are hypersensitive to penicillin.

 Erythromycin suspension CONTRAINDICATIONS :

Hypersensitivity to erythromycin and in patients who have previously developed hepatic dysfunction while receiving it.

Erythromycin suspension  PRECAUTIONS :

Erythromycin pharco should be used with care in patients with existing liver disease.
As with other antibiotics, prolonged therapy may result in overgrowth of non- susceptible microorganisms.

 Erythromycin suspension PREGNANCY AND LACTATION :

No teratogenic or harmful fetal effects have been reported in animal studies. However, Erythromycin pharco should be used cautiously during pregnancy and lactation and only if clearly indicated.

 Erythromycin suspension ADVERSE EFFECTS :

Rarely, gastrointestinal disturbances, such as abdominal cramps, nausea, vomiting and diarrhea might occur and are dose-related. Skin rashes, urticaria or other mild allergic reactions may rarely occur.

 Erythromycin suspension DRUG INTERACTIONS :

Erythromycin pharco administration in patients concurrently treated with theophylline, digoxin, ergotamine, dihydroergotamine, triazolam, astemizole, carbamazepine, cyclosporin, hexobarbital or phenytoin may elevate their serum levels and potentiate their effects. Erythromycin pharco,administration also potentiates the effects of oral anticoagulants.

 Erythromycin suspension DOSAGE AND ADMINISTRATION :

Preparation of the suspension: Shake the bottle to loosen the powder. Then add water gradually with shaking until the reconstituted suspension is at the marking level (60 ml) on the bottle. The resultant suspension will provide 200 mg erythromycin activity per teaspoonful (5 ml). Once reconstituted, the suspension is stable for 7 days at ( 15 – 30° C) or 14 days in the refrigerator (4° C).
Children: The dose depends upon the age and severity of infection. The recommended dose is 30 – 50 mg I kg I day in equally divided doses every 6, 8 or 12 hours (Table).
Body weight                      Total daily dosage
5 -10 kg                                        400mg
10-25kg                                        800 mg
over 25 kg                                    1200 mg
In streptococcal infection: Treatment with Erythromycin pharco should be continued for at least 10 days.
Prophylaxis against bacterial endocarditis: 20 mg I kg orally, 1.5 – 2 hours before the procedure and then 10 mg/kg every 6 hours for two days.

 Erythromycin suspension OVERDOSAGE  :

Erythromvcin pharco  is safe in the recommended dosag In case of overdosage, administration of the drug should be discontinued immediately with proper elimination of unabsorbed drug. Peritoneal dialysis and hemodialysis are not effective for removal of erythromycin from the body.

Packing:   

A bottle containing powder for 60 ml oral suspension.

Storage:   

Before reconstitution store at ( 15 – 30° C ) away from moisture.
Keep out of the reach of children.

 Produced by :   

PHARCO  PHARMAaUTlCALS
ALEXANDRIA.

Tags: Erythromycinpharco pharmaceuticals
Drug Index

Drug Index

Search Videos

  • About
  • Privacy & Policy
  • Contact

© 2008-2019 Meduweb.

No Result
View All Result
  • Home
  • Free Medical Videos
  • Online Pharmacy
  • Ophthalmology
  • Gynecology and Obstetrics

© 2008-2019 Meduweb.

Welcome Back!

OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT

Add New Playlist